Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06450925 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Vitamin A Supplementation in Allogeneic Stem Cell Transplantation.

StatusRecruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

  1. Eligibility criteria expanded, about 29 wordsv9 See this version in full on ClinicalTrials.gov ↗
  2. Trial status: Not Yet Recruiting to Recruiting Primary completion date: Mar 2028 to Aug 2027 · Completion date: Mar 2030 to Aug 2029 · Start date changed from estimate of Mar 2025 to Mar 25, 2025 · 1 morev8 Show 4 more changesShow less
    • Primary completion date: Mar 2028 to Aug 2027
    • Completion date: Mar 2030 to Aug 2029
    • Start date changed from estimate of Mar 2025 to Mar 25, 2025
    • Site details revised at 3 of 3 sites
  3. Re-verified, no change to tracked fieldsv7
  4. Primary completion date: Aug 2027 to Mar 2028 Start date: Nov 2024 to Mar 2025 · Completion date: Aug 2029 to Mar 2030v6 Show 2 more changesShow less
    • Start date: Nov 2024 to Mar 2025
    • Completion date: Aug 2029 to Mar 2030
  5. Start date: Oct 2024 to Nov 2024v5
Show 3 earlier versionsHide 3 earlier versions
  1. Eligibility criteria expanded, about 15 wordsv4 See this version in full on ClinicalTrials.gov ↗
  2. Phase: Not applicable to Phase 2 Interventions: Placebo (Other), Vitamin A (Dietary Supplement) to Placebo (Other), Vitamin A (Drug)v3 Show 1 more changeShow less
    • Interventions: Placebo (Other), Vitamin A (Dietary Supplement) to Placebo (Other), Vitamin A (Drug)
  3. Primary endpoint revised Secondary endpoints revised (3) · Study title shortened, about 6 words · Study description expanded, about 2 wordsv2 Show 3 more changesShow less
    • Secondary endpoints revised (3)
    • Study title shortened, about 6 words
    • Study description expanded, about 2 words

    See this version in full on ClinicalTrials.gov ↗

  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The investigators hypothesize that single oral high dose supplementation with vitamin A will reduce the incidence of moderate-severe chronic graft-versus-host disease (GVHD) compared with placebo.
Trial Details
NCT Number NCT06450925
Lead Sponsor Children's Hospital Medical Center, Cincinnati
Conditions Graft Vs Host Disease, Vitamin A Deficiency, Vitamin D Deficiency
Enrollment 190 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov